Built on talent, technology, and trust, Grace is a leading global supplier of catalysts and engineered materials. The company’s two industry-leading business segments—Catalysts Technologies and Materials Technologies—provide innovative…

EXCiPACT asbl is pleased to announce that the W. R. Grace site in Baltimore, Maryland, USA has recently been awarded an EXCiPACT GMP Certificate from SGS, one of EXCIPACT’s internationally recognised Certification Bodies. The Certificate…

At this year's 10th DDF Summit in Berlin, Fred Monsuur from GRACE held a presentation on Mesoporous Silica DDS - An Option for Liquisolid Drug Delivery Systems. Did you miss the event and or want to have a look at the slides again? We…

22. December 2017 Grace’s SILSOL® technology offers solutions for poorly soluble active ingredients. Based on compendial silica and fully scalable, it gives pharmaceutical developers new…

18. October 2017 WR Grace & Co has licensed rights to a bioavailability enhancement technology from Formac Pharmaceuticals NV. Excipients and Drug Delivery Syloid® silica excipients are the…

13. November 2015 Grace Syloid Silica Gels &  Mesoporous Silica in the field of Drug Delivery Friday, November 27, 2015 at Safran Zunft in Basel 10.00 Morning session organized by IMPAG…

WORMS, GERMANY – May 26, 2015 – W. R. Grace & Co. (NYSE: GRA) announces that its manufacturing facility in Worms, Germany has received good manufacturing practice (GMP) certification from EXCiPACT™, an independent organization that…